ResMed Inc.
No trades
No trades
Fundamentals and stats
EPS and revenue snapshot
In the last quarter, the company reported 2.48 EUR per share, beating the 2.42 EUR estimate by 2.32%. Revenue for the same period reached 1.24 B EUR, despite the estimate of 1.23 B EUR. For the next quarter, analysts expect 2.53 EUR in earnings per share and 1.28 B EUR in revenue.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise